Admission Date:  [**2109-9-24**]              Discharge Date:   [**2109-10-17**]  Date of Birth:  [**2030-1-16**]             Sex:   F  Service: SURGERY  Allergies: Heparin Agents  Attending:[**First Name3 (LF) 3376**] Chief Complaint: abdominal pain  Major Surgical or Invasive Procedure: Acute perineal resection   History of Present Illness: 79F with biopsy proven stage III T3N1 rectal cancer who recently finished XRT on [**2109-9-7**] presents with 2 weeks of nonspecific abdominal pain.
Past Medical History: Dementia-presumed, undergoing w/u with Dr. [**Last Name (STitle) **] h/o ETOH abuse-pt denies Newly diagnosed rectal cancer Chronic intermittent diarrhea/fecal incontinence, being w/u urinary urge incontinence Anxiety/depression Cataracts, awaiting surgery Chronic multifactorial debility [**12-31**] arthritis, loss of function RUE after fall, back pain, balance issues-mostly wheelchair, but is able to ambulate Smoker s/p L ankle surgery s/p ovarian cyst removal s/p Appy   Social History: Married.
Perineal incision OTA with sutures, serosanguinous drainage.
Pertinent Results: Micro/Imaging: [**2109-10-16**] PICC line inserted in RUE via Interventional radiology [**2109-10-15**] RUE and B/L LE U/S negative [**2109-10-14**] LUE U/S occlusive thrombus of L subclv, axillary, brachialis, and basilic [**2109-10-10**] URINE URINE CULTURE-FINAL {YEAST} [**2109-10-6**] CXR no opacities.
loc eff on R. focal opacities RU+[**Doctor Last Name **] ?inf vs. atelec [**2109-10-3**] Cdif neg [**2109-10-1**] Bcx NGTD [**2109-9-30**] CXR worsening opacity, ?central obstruction, b/l effusions [**2109-9-30**] CT chest collapse of RML, known COPD, ?adrenal met b/l pl effusions [**2109-9-30**] Ucx no growth UA:sm leuks, neg nit no bact [**2109-9-30**] Bcx no growth [**2109-9-28**] Cdiff neg [**2109-9-27**] CXR RLL infiltrate [**2109-9-24**] Ucx neg UA: mod leuks, neg nit, rare bact [**2109-9-24**] Stool cx Neg [**2109-9-24**] Bcx NGTD [**2109-9-24**] CT rectal ca w/o mets, patent graft, pulmonary nodule, ?r asp PNA, DJD  [**2109-9-24**] 10:40AM BLOOD WBC-7.4 RBC-4.21 Hgb-12.5 Hct-38.1 MCV-90 MCH-29.6 MCHC-32.8 RDW-14.8 Plt Ct-298 [**2109-9-25**] 03:44AM BLOOD WBC-7.5 RBC-3.93* Hgb-12.0 Hct-36.1 MCV-92 MCH-30.6 MCHC-33.3 RDW-14.2 Plt Ct-291 [**2109-9-30**] 06:50AM BLOOD WBC-15.9* RBC-4.01* Hgb-12.0 Hct-37.4 MCV-93 MCH-30.0 MCHC-32.2 RDW-14.7 Plt Ct-584* [**2109-10-10**] 01:30AM BLOOD WBC-26.0*# RBC-3.15* Hgb-9.4* Hct-29.4* MCV-93 MCH-29.7 MCHC-31.9 RDW-15.5 Plt Ct-75* [**2109-10-11**] 03:30AM BLOOD WBC-13.8* RBC-2.27*# Hgb-6.7*# Hct-21.5*# MCV-95 MCH-29.5 MCHC-31.0 RDW-16.1* Plt Ct-65* [**2109-10-14**] 06:10AM BLOOD WBC-14.8* RBC-3.38* Hgb-10.2* Hct-30.5* MCV-90 MCH-30.3 MCHC-33.6 RDW-15.7* Plt Ct-28* [**2109-10-15**] 05:55AM BLOOD WBC-12.3* RBC-3.47* Hgb-10.4* Hct-31.8* MCV-92 MCH-29.9 MCHC-32.5 RDW-15.4 Plt Ct-41* [**2109-10-16**] 05:25AM BLOOD WBC-12.4* RBC-3.27* Hgb-9.9* Hct-30.0* MCV-92 MCH-30.2 MCHC-33.0 RDW-15.3 Plt Ct-52* [**2109-10-15**] 05:55AM BLOOD PT-28.3* PTT-71.3* INR(PT)-2.8* [**2109-10-11**] 10:30PM BLOOD PT-16.4* PTT-31.5 INR(PT)-1.5* [**2109-9-27**] 07:45AM BLOOD PT-12.4 PTT-26.9 INR(PT)-1.0 [**2109-9-24**] 10:40AM BLOOD PT-11.6 PTT-28.0 INR(PT)-1.0 [**2109-10-11**] 10:36AM BLOOD Fibrino-176 [**2109-10-10**] 01:30PM BLOOD Fibrino-270 [**2109-10-11**] 10:36AM BLOOD FDP-0-10 [**2109-9-30**] 03:20PM BLOOD ESR-0 [**2109-10-15**] 05:55AM BLOOD Glucose-81 UreaN-17 Creat-0.9 Na-141 K-4.2 Cl-99 HCO3-31 AnGap-15 [**2109-10-14**] 06:10AM BLOOD Glucose-79 UreaN-15 Creat-0.9 Na-141 K-3.4 Cl-98 HCO3-34* AnGap-12 [**2109-10-13**] 05:54AM BLOOD Glucose-84 UreaN-12 Creat-0.7 Na-141 K-3.9 Cl-102 HCO3-31 AnGap-12 [**2109-10-12**] 12:49PM BLOOD Glucose-103 UreaN-12 Creat-0.7 Na-142 K-3.4 Cl-102 HCO3-31 AnGap-12 [**2109-10-11**] 03:30AM BLOOD Glucose-80 UreaN-13 Creat-0.8 Na-141 K-4.0 Cl-106 HCO3-25 AnGap-14 [**2109-9-29**] 05:00AM BLOOD Glucose-145* UreaN-11 Creat-0.9 Na-141 K-3.6 Cl-105 HCO3-24 AnGap-16 [**2109-9-27**] 07:45AM BLOOD Glucose-116* UreaN-8 Creat-0.4 Na-142 K-4.1 Cl-107 HCO3-30 AnGap-9 [**2109-9-25**] 03:44AM BLOOD Glucose-88 UreaN-9 Creat-0.4 Na-139 K-3.6 Cl-102 HCO3-22 AnGap-19 [**2109-9-24**] 10:40AM BLOOD Glucose-116* UreaN-12 Creat-0.4 Na-138 K-3.8 Cl-101 HCO3-28 AnGap-13 [**2109-9-29**] 05:00AM BLOOD CK(CPK)-28 [**2109-9-24**] 10:40AM BLOOD ALT-25 AST-19 AlkPhos-54 TotBili-0.6 [**2109-9-29**] 05:00AM BLOOD CK-MB-3 cTropnT-<0.01 [**2109-9-24**] 10:40AM BLOOD Lipase-10 [**2109-10-15**] 05:55AM BLOOD Calcium-7.6* Phos-3.0 Mg-2.4 [**2109-10-14**] 06:10AM BLOOD Calcium-7.4* Phos-3.6 Mg-1.7 [**2109-10-13**] 05:54AM BLOOD Calcium-7.6* Phos-3.4 Mg-2.2 [**2109-10-11**] 10:36AM BLOOD Albumin-2.7* [**2109-9-24**] 10:40AM BLOOD Albumin-3.1* Calcium-8.6 Phos-3.6 Mg-1.5* [**2109-9-25**] 03:44AM BLOOD Albumin-2.9* Calcium-8.3* Phos-3.6 Mg-1.4* Iron-18* [**2109-9-27**] 07:45AM BLOOD Calcium-8.5 Phos-2.5* Mg-2.1 [**2109-9-25**] 03:44AM BLOOD calTIBC-194* Ferritn-128 TRF-149* [**2109-9-25**] 03:44AM BLOOD Triglyc-109  Brief Hospital Course: [**Hospital Unit Name 153**] Course  79 yo female with mild dementia, recent HAP, pleural effusions with stage III rectal cancer now s/p perineal resection (including sigmoidectomy, protectomy, resection of portion of colon) with uncomplicated operative course who was admitted to [**Hospital Unit Name 153**] on [**2109-10-10**] for monitoring post-operatively.
No antibiotics were initiated and WBC count trended down by ICU Day #2.
The patient was given IV Morphine PRN for pain control.
Because of a concern for HIT due to long-term exposure to Heparin in this patient, Heparin was discontinued and the patient was switched to pneumoboots for DVT Prophylaxis.
Albumin and prealbumin were sent out to assess nutritional status.
COPD: The patient received albuterol/ipratropium nebs for her COPD.
Patient was admitted to the general surgery service for better control of her abdominal pain and management of her nutrition prior to her scheduled surgery.
She was kept NPO and given IVF.
Her pain was well controlled with Tylenol and Morphine as needed.
Geriatics was consulted for assistance with medical management prior to surgery.
They made recommendations for prevention of delirium, management of her COPD and pain.
She was scheduled for surgery on [**9-27**], for which she prepared with a bowel prep on the preceding day.
Anesthesia was concerned about the patient's respiratory status.
She was started on a 5 day course of IV vancomycin and zosyn and returned to a regular diet.
Her FeNa was 2.1 and therefore her renal failure was thought to be from intrinisic renal failure, likely acute tubular necrosis.
Following this information, she was transferred to the medicine service for further management of her renal and pulmonary issues.
Although the patient was not an optimal surgical candidate, surgery was thought to be delayed until another time rather than cancelled.
The patient suffers from COPD which continued to benefit from her nebulizer regimen.
She was maintained on ipratropium bromide (Q6H)  and albuterol 0.083% Q6H.
She received a magnesium citrate bowel prep the day before surgery.
She was C. Diff negative and therefore was placed on her home regimen of loperamide.
Over her stay, the patient complained of vague abdominal, R ankle/knee, L-thigh, back pain, bilateral arm pain, and R-shoulder pain.
She did not consistently focus on any specific spot on a day-to-day basis.
Her pain medication regimen was limited to acetaminophen, lidocaine patches and tramadol.
Continued with nebulizers and aggressive Chest PT.
Completed full anitbiotic regimen for treatment of Pre-op pneumonia.
All heparin agents discontinued.
Patient started on an Argatroban drip.
Heme/Onco advised continuing argatroban drip untile platelets above 100,000 for at least 48hours, then convert to PO Coumadin.
IV fluid discontinued.
Medications on Admission: tylenol, nystatin powder, imodium, potassium supplement, vitamin  Discharge Medications: 1.
Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical Q24 () as needed for pain.
Tramadol 50 mg Tablet Sig: 0.5 Tablet PO Q4H (every 4 hours) as needed for pain for 2 weeks: Hold for somnolence, RR<12.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: Two (2)  Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
Ipratropium Bromide 0.02 % Solution Sig: Two (2)  Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q 8H (Every 8 Hours) as needed for pain: Do not exceed 4000mg in 24hrs.
Fluconazole 100 mg Tablet Sig: Two (2) Tablet PO Q24H (every 24 hours) for 1 weeks.
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID (3 times a day) as needed for fungal infection: apply under breasts & perineal area .
Argatroban 100 mg/mL Solution Sig: 0.5-2 mcg/kg/min Intravenous INFUSION (continuous infusion): Refer to attached protocol.
Discharge Disposition: Extended Care  Facility: [**Hospital6 459**] for the Aged - MACU  Discharge Diagnosis: stage III T3N1 rectal cancer completed XRT [**2109-9-7**] pre-op treatment of pneumonia post-op DVT-LUE post-op stage II ulcer of coccyx Positive for heparin induced thrombocytopenia  Discharge Condition: Alert & oriented x3 Tolerating a regular diet with supplements Pain well controlled with oral Ultram and Tylenol  Discharge Instructions: REHAB Instruction: Please call the doctor or return to the ER for any of the following: * You experience new chest pain, pressure, squeezing or tightness.
*Avoid driving or operating heavy machinery while taking pain medications.
* Please resume all regular home medications and take any new meds as ordered.
Monitoring Ostomy output/Prevention of Dehydration: -Keep well hydrated.
Anticoagulation: -Continue Argatroban drip [**First Name8 (NamePattern2) **] [**First Name8 (NamePattern2) **] [**Hospital3 66399**] protocol and adhere to modifications per Hematology/Oncolgy specialists (see enclosed note & Instruction section).
